Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Lupin Limited | Nagpur, India | Makes it and packages it | Problems found, fixed voluntarilySep 16, 2025 · 1 inspection |
Recalls
- Jun 23, 2026 · Class II · Lupin Pharmaceuticals Inc.
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
Lots: Kit Lots: WB00010, Exp. Date Jan 2027; WB00017, WB00019, Exp. Date Feb 2027; WB00070, Exp. Date Jun 2027; WB00077, WB00078, Exp. Date Jul 2027; WB00130, Exp. Date Nov 2027.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Glucagon: every company that makes it
- Form
- kit
- Strength
- 1 mg per 1 mL
- Approval
- ANDA ANDA214457
- On the market since
- Aug 4, 2025
- Package NDCs
70748-309-0170748-310-0170748-311-01- Official label
- DailyMed (National Library of Medicine), updated Oct 29, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?